Home
Conditions
Lung Cancer (NSCLC)

Clinical trial condition

Lung Cancer (NSCLC)

Explore clinical trials studying Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

113 public trials 49 recruiting studies

Refine in advanced search Browse all conditions

Lung Cancer (NSCLC) trial results

Not yet recruiting

Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver Mutations

NCT07829744

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Percutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and Lung Oligometastases: A Safety and Efficacy Study

NCT07799194

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Affiliated Hospital of Guagnzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC

NCT07802834

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies

NCT07789912

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +19 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Not yet recruiting

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

NCT07781852

Conditions: Adnexal Diseases, Astrocytoma, Bladder Cancer, +84 more
Locations: Massachussetts General Hospital Boston, Massachusetts, United States

BAMF Health Grand Rapids, Michigan, United States

East River Medical Imaging New York, United States

View Trial Details

Not yet recruiting

First-line Therapy With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor(EGFR-TKI) Combined With Trastuzumab Rezetecan for Advanced Non-small Cell Lung Cancer(NSCLC) Harboring EGFR Mutations Concomitant With Human Epidermal Growth Factor Receptor 2(HER2) Alterations

NCT07699952

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

NCT07436858

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: The Netherlands Cancer Institute - Antoni van Leeuwenhoek Amsterdam, North Holland, Netherlands

View Trial Details

Not yet recruiting

Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients

NCT07742800

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not yet recruiting

Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC

NCT07722182

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Prince of Wales Hospital Hong Kong

View Trial Details

Not yet recruiting

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

NCT07482605

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations: Not specified

View Trial Details

Lung Cancer (NSCLC)

Lung Cancer (NSCLC) trial results

Related conditions